|
|
Vaccine Detail
|
CJ-50300 |
| Vaccine Information |
- Vaccine Name: CJ-50300
- Target Pathogen: Variola virus
- Target Disease: Smallpox
- Type: Live, attenuated vaccine
- Status: Licensed
- Host Species for Licensed Use: Human
- Preparation: CJ-50300 was derived from vaccinia virus strain ATCC VR-118 (originating from the New York City Board of Health vaccinia strain), adapted to replicate in MRC-5 cells under serum-free conditions. Harvested cells were lysed, centrifugated and filtrated. The final bulk was aseptically filled in glass vials and freeze-dried. (Kim et al., 2013)
- Immunization Route: Intramuscular injection (i.m.)
- Virulence: Freeze-dried CJ-50300 was reconstituted with 0.3mL glycerin–phenol diluent and used within 1 hour. (Kim et al., 2013)
- Description: CJ-50300 was derived from vaccinia virus strain ATCC VR-118 adapted to replicate in MRC-5 cells. (Kim et al., 2013)
|
| Host Response |
|
|
| References |
|
|
|
